Progressive - I think you are right, in part. There are many people who have been monitoring the p53 research progress over the past couple of decades. Many will jump in if kevetrin shown to be active on p53, based on non-genotxic lab studies. Many others will wait until tolerability and low toxicity proven in patients. And those who wait for tumor reduction results will probably miss the ride!